| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |